StockData
Coya Therapeutics, Inc. logo

Coya Therapeutics, Inc. (COYA) stock

COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/3017% above fair value
$3.09+0.07 (+2.32%)

Close on Nov 18, 2026Market cap $72.48MP/E –Yield –

Coya Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Coya Therapeutics's price to sales ratio was 9.4× on Nov 11, 2026, against 27.3× a year earlier. Over the last 3 years it ranged from 9.1× to 259.1×, with a median of 17.3×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20269.4×−15.0
2025Dec 31, 202524.4×+15.2
2024Dec 31, 20249.1×–

More Coya Therapeutics figures

See a number that looks wrong?